Last Updated: June 6, 2026

Suppliers and packagers for BENAZEPRIL HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


BENAZEPRIL HYDROCHLORIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Amneal Pharms BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076820 ANDA AvPAK 50268-109-15 50 BLISTER PACK in 1 BOX (50268-109-15) / 1 TABLET in 1 BLISTER PACK (50268-109-11) 2014-04-28
Amneal Pharms BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076820 ANDA AvPAK 50268-110-15 50 BLISTER PACK in 1 BOX (50268-110-15) / 1 TABLET in 1 BLISTER PACK (50268-110-11) 2014-04-28
Amneal Pharms BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076820 ANDA AvPAK 50268-111-15 50 BLISTER PACK in 1 BOX (50268-111-15) / 1 TABLET in 1 BLISTER PACK (50268-111-11) 2014-04-28
Amneal Pharms BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076820 ANDA AvPAK 50268-112-15 50 BLISTER PACK in 1 BOX (50268-112-15) / 1 TABLET in 1 BLISTER PACK (50268-112-11) 2014-04-28
Amneal Pharms BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076820 ANDA Northwind Health Company, LLC 51655-755-26 90 TABLET in 1 BOTTLE, PLASTIC (51655-755-26) 2023-04-03
Amneal Pharms BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076820 ANDA Northwind Health Company, LLC 51655-755-52 30 TABLET in 1 BOTTLE, PLASTIC (51655-755-52) 2023-04-03
Amneal Pharms BENAZEPRIL HYDROCHLORIDE benazepril hydrochloride TABLET;ORAL 076820 ANDA Amneal Pharmaceuticals of New York LLC 53746-751-01 100 TABLET in 1 BOTTLE (53746-751-01) 2022-09-26
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Benazepril Hydrochloride: Supplier Landscape and Procurement-Grade Details

Last updated: April 24, 2026

Who supplies benazepril hydrochloride for pharma-grade manufacturing?

Benazepril hydrochloride is typically sourced in one of three supply models: (1) API from established API manufacturers, (2) intermediate-linked API supply chains that integrate fermentation/chemical synthesis, and (3) finished-dose manufacturers who source the API externally for tablets. In procurement practice, buyers screen suppliers by (a) DMF/CEP availability, (b) cGMP status, (c) regulatory history (FDA/EMA inspections), and (d) technical dossier completeness (CoA, specs, stability, polymorph/solvate statements).

Which supplier types should buyers target for benazepril hydrochloride API?

Procurement teams usually target these categories, ranked by how directly they de-risk filings and scale-up:

  • API manufacturers with regulatory dossiers: Vendors that support US FDA DMF and/or EU CEP filings for benazepril hydrochloride.
  • Contract manufacturers with API capability: Firms producing the API under cGMP with batch documentation that supports quality agreements.
  • Distributors/chemical suppliers: Often fast for sampling, but buyers still need DMF/CEP alignment for commercial supply.

What documentation typically defines a compliant benazepril hydrochloride API supply?

Buyers generally require:

  • DMF (US) or CEP (EU) for the API entry used in the target market.
  • cGMP certificate corresponding to API manufacturing site(s).
  • API specifications covering appearance, assay, impurities, residual solvents, water content, and particle-related attributes if relevant to the dosage form.
  • Stability data (ICH zones) with defined retest period and storage conditions.
  • Stereochemical and polymorph controls (benazepril hydrochloride has defined salt form identity requirements in pharmacopoeial use).
  • Change control and tech transfer support for scale.

Which markets drive which benazepril hydrochloride supplier expectations?

Benazepril is marketed in multiple geographies, which changes the compliance load:

  • US: DMF-linked procurement is common for brand and generic API supply chains.
  • EU: CEP-linked procurement is common where the marketing authorization strategy uses EU dossier reliance.
  • Global: Buyers often ask for site-level inspection history, especially for impurity control and reproducibility.

Supplier short-list for benazepril hydrochloride (API and supply-chain providers)

The supplier universe for benazepril hydrochloride is broad, but only a subset consistently supports dossier-linked supply for pharma-grade use. The table below lists manufacturers and quality-dossier-capable suppliers that have publicly described API or pharmaceutical supply activities for benazepril hydrochloride in trade and company literature.

Supplier table (procurement-oriented)

Supplier Supply role Primary relevance for buyers What to validate in onboarding
Synthon Pharmaceuticals API manufacturer / pharma supply Long-running generic and API ecosystem; supports regulated pharma supply chains DMF/CEP availability for the specific grade; site cGMP; impurity profile alignment
Mylan (Viatris) Finished-dose and generic supply chain Uses internally and via qualified suppliers; important for dossier lineage in generics Which API site supplies the commercial lots; DMF reference linkage
Hikma Pharmaceuticals Generic pharma supply chain Strong dossier and quality system depth API source confirmation; spec sheet and batch release criteria
Aurobindo Pharma Generic pharma and API ecosystem API integration in multiple therapeutic areas API manufacturing site; impurity control documentation
Hetero Drugs Generic pharma and API ecosystem Large-scale generic manufacturing footprint API supplier statement; cGMP certification
Zydus Lifesciences Generic pharma and API ecosystem Pharma quality systems with established supply practices DMF/CEP status; stability and impurity controls
Teva Pharmaceuticals Generic pharma supply chain High compliance maturity; sourcing visibility Confirm API supplier; grade/spec matching
Dr. Reddy’s Laboratories Generic and API ecosystem Strong regulated manufacturing record API source and DMF/CEP alignment for the target market
Torrent Pharmaceuticals Generic pharma supply chain Market presence across geographies Confirm API chain-of-custody; dossier linkage
Accord BioPharma (Accord group, where applicable) Generic manufacturing ecosystem Dossier-supported supply for generics API site and quality agreement requirements

Source basis: The supplier entries above reflect company-level public positioning in regulated generic manufacturing and API ecosystems commonly used in dossier-backed supply chains for API-grade benazepril hydrochloride. For procurement execution, buyers still need DMF/CEP and batch release proof tied to the exact API grade and manufacturing site.

How to use regulatory and dossier references to confirm benazepril hydrochloride suppliers

Procurement-grade supplier confirmation typically uses:

  • FDA DMF holders and cross-references: Identify DMF-linked manufacturers for the API grade and confirm the manufacturing site for the DMF.
  • EU CEP: Confirm the salt form and the manufacturing site referenced in the CEP.
  • US FDA Inspection reports: Use site history to assess deviation trends relevant to impurity control.
  • Ph. Eur./USP alignment: Validate that the supplier’s specs match pharmacopoeial requirements for benazepril hydrochloride.

What procurement specs should be locked before purchase

For benazepril hydrochloride API, procurement teams usually lock:

  • Assay and impurity thresholds (related substances and any nitrosamine-related risk, if required by the buyer’s risk framework and current regulatory guidance).
  • Residual solvents (Class 1, 2, 3 as applicable).
  • Water content (Karl Fischer if used).
  • Particle size or sieve compliance if the dosage form depends on it.
  • Salt identity via standard analytical methods (HPLC/LC-MS with defined method, IR, or comparable identification tests).
  • Stability: retest period, storage conditions, and drift acceptance bands for assay and impurities.

Key buyer actions for supplier onboarding (fast path)

  • Require CoA format alignment and batch traceability fields (lot-to-raw-material link).
  • Request spec sheet and test methods aligned to the targeted market registration.
  • Confirm DMF/CEP linkage or provide a dossier letter referencing the supplier’s DMF/CEP.
  • Execute a quality agreement that covers deviation handling, change control, and analytical method transfer rules.
  • Set up incoming inspection plan for first three commercial-equivalent lots.

Key Takeaways

  • Benazepril hydrochloride is commonly supplied through regulatory-dossier-linked API ecosystems rather than purely commodity chemical distribution for pharma-grade launches.
  • Buyers should prioritize vendors that can support DMF (US) and/or CEP (EU) for the exact API grade and manufacturing site.
  • Procurement success depends on locking impurity specs, residual solvents, salt identity, and stability before signing commercial supply terms.

FAQs

1) Do suppliers for benazepril hydrochloride usually provide DMF or CEP?

Pharma-grade suppliers typically provide DMF/CEP support or dossier-referenced quality documentation. Buyers should confirm the exact dossier linkage to the manufacturing site and the API grade.

2) Is benazepril hydrochloride supplied as an intermediate or finished API only?

It is predominantly supplied as API (benazepril hydrochloride salt) for finished-dose manufacturing. Some upstream supply chains support intermediates, but commercial supply for tablets generally uses API.

3) What specs matter most for benazepril hydrochloride API procurement?

Assay, related substances/impurities, residual solvents, water content, salt identity, and stability/retest period are the core procurement specifications.

4) How do buyers validate supplier quality beyond a CoA?

They validate dossier linkage (DMF/CEP), request test methods, review inspection and deviation summaries, and run incoming inspection and first-lot qualification.

5) Can distributors supply benazepril hydrochloride for commercial use?

Distributors can supply for sampling or interim supply, but commercial-quality use generally requires dossier-grade proof that ties the delivered API lot to the qualified manufacturing site and regulatory documentation.


References

[1] FDA. Drugs@FDA database. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] European Directorate for the Quality of Medicines (EDQM). European Public Assessment Reports and CEP-related resources. https://www.edqm.eu/
[3] EMA. Public assessment and product information resources. https://www.ema.europa.eu/
[4] USP. USP standards and monographs for pharmaceutical substances (benazepril hydrochloride relevant monographs where applicable). https://www.uspnf.com/

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.